by Daniel ShvartsmanEuropean markets traded higher Tuesday as general market bullishness - or complacency appears to have set in for investors.At 12:50 CET (1150 GMT) the DAX...
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Oil & Gas, Financials and Industrials sectors led shares lower. At the close in NYSE, the Dow...
Investing.com – France stocks were higher after the close on Thursday, as gains in the Foods & Drugs, Gas & Water and General Financial sectors led shares higher. At the close in...
As of late, it has definitely been a great time to be an investor in Genfit SA (NASDAQ:GNFT) . The stock has moved higher by 2.2% in the past month, while it is also above its 20...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) gained 3.02% after the company posted mixed results for the first quarter. The company reported a wider-than-expected loss but beat...
For Immediate ReleaseChicago, IL – May 1, 2019 - Stocks in this week’s article Teledyne Technologies Inc. (NYSE:TDY) , Genfit SA (NASDAQ:GNFT) , Shoe Carnival...
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company’s products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Sell | Strong Sell | Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 93.12 | 94.34 | 87.10 | +4.35 | +4.90% | 3.51M | NASDAQ | |||
| 92.65 | 93.89 | 89.52 | +1.49 | +1.63% | 109.22M | NASDAQ | |||
| 114.98 | 119.00 | 102.54 | +9.51 | +9.02% | 4.44M | NYSE | |||
| 307.81 | 316.97 | 304.62 | -9.64 | -3.04% | 486.43K | NYSE | |||
| 82.31 | 84.07 | 81.07 | -0.16 | -0.19% | 22.86M | NYSE | |||
| 8.16 | 8.19 | 7.96 | -0.08 | -0.97% | 4.69M | NYSE | |||
| 237.51 | 247.19 | 232.39 | -5.64 | -2.32% | 1.53M | NYSE | |||
| 130.85 | 133.00 | 126.28 | -1.21 | -0.92% | 5.32M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 39.40 | 39.60 | 38.84 | +0.64 | +1.65% | 5.85M | NYSE | |||
| 0.1922 | 0.2025 | 0.1896 | -0.0158 | -7.60% | 1.43M | NYSE | |||
| 1.15 | 1.15 | 1.11 | +0.0200 | +1.77% | 4.63M | NYSE | |||
| 2.54 | 2.68 | 2.30 | +0.160 | +6.72% | 11.66M | NYSE | |||
| 232.61 | 234.61 | 230.82 | +0.30 | +0.13% | 1.02M | NYSE | |||
| 690.88 | 699.63 | 684.70 | +4.86 | +0.71% | 560.77K | NASDAQ |